Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

“Adolescents living with moderate to severe plaque psoriasis shouldn’t have to wait for effective treatment options that have ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat ... options if chlorine doesn’t aggravate your skin. Walking during the morning or evening hours ...

which enrolled adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis. Top-line results show that 64.7% of patients achieved clear or almost clear skin measured ...